Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry Greenberg

Showing results (141-150 of 189) with videos related to

Pageof 19
Sort By:
American Heart Journal|February 7, 2012
Design of the RELAXin in acute heart failure studyPiotr Ponikowski, Marco Metra, John R Teerlink, et al.
European Journal of Heart Failure|September 22, 2020
Plasma D-dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: an analysis from the COMMANDER-HF trialJoão Pedro Ferreira, Carolyn S P Lam, Stefan D Anker, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 9, 2021
Heart failure re-hospitalizations and subsequent fatal events in coronary artery disease: insights from COMMANDER-HF, EPHESUS, and EXAMINEJoão Pedro Ferreira, John G Cleland, Carolyn S P Lam, et al.
Lancet (London, England)|January 25, 2016
Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trialBarry Greenberg, Javed Butler, G Michael Felker, et al.
European Journal of Heart Failure|July 18, 2023
Mineralocorticoid receptor antagonist initiation during admission is associated with improved outcomes irrespective of ejection fraction in patients with acute heart failureIris E Beldhuis, Kevin Damman, Peter S Pang, et al.
Journal of Cardiac Failure|August 28, 2010
Effects of ACE2 inhibition in the post-myocardial infarction heartMyung-A Kim, Dongheon Yang, Keisuke Kida, et al.
Journal of Alzheimer'S Disease : JAD|October 18, 2024
A Randomized-Controlled Trial Targeting Cognition in Early Alzheimer's Disease by Improving Sleep with Trazodone (REST)Estelle Eyob, Jacob S Shaw, Arnold Bakker, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 19, 2011
Permutation criteria to evaluate multiple clinical endpoints in a proof-of-concept study: lessons from Pre-RELAX-AHFBeth A Davison, Gad Cotter, Hengrui Sun, et al.
JACC. Heart Failure|May 9, 2015
Worsening Heart Failure Following Admission for Acute Heart Failure: A Pooled Analysis of the PROTECT and RELAX-AHF StudiesBeth A Davison, Marco Metra, Gad Cotter, et al.
European Heart Journal|August 29, 2019
A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trialMandeep R Mehra, Muthiah Vaduganathan, Min Fu, et al.
Pageof 19

Showing results (141-150 of 189) with videos related to

Sort By:
Pageof 19
American Heart Journal|February 7, 2012
Design of the RELAXin in acute heart failure studyPiotr Ponikowski, Marco Metra, John R Teerlink, et al.
European Journal of Heart Failure|September 22, 2020
Plasma D-dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: an analysis from the COMMANDER-HF trialJoão Pedro Ferreira, Carolyn S P Lam, Stefan D Anker, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 9, 2021
Heart failure re-hospitalizations and subsequent fatal events in coronary artery disease: insights from COMMANDER-HF, EPHESUS, and EXAMINEJoão Pedro Ferreira, John G Cleland, Carolyn S P Lam, et al.
Lancet (London, England)|January 25, 2016
Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trialBarry Greenberg, Javed Butler, G Michael Felker, et al.
European Journal of Heart Failure|July 18, 2023
Mineralocorticoid receptor antagonist initiation during admission is associated with improved outcomes irrespective of ejection fraction in patients with acute heart failureIris E Beldhuis, Kevin Damman, Peter S Pang, et al.
Journal of Cardiac Failure|August 28, 2010
Effects of ACE2 inhibition in the post-myocardial infarction heartMyung-A Kim, Dongheon Yang, Keisuke Kida, et al.
Journal of Alzheimer'S Disease : JAD|October 18, 2024
A Randomized-Controlled Trial Targeting Cognition in Early Alzheimer's Disease by Improving Sleep with Trazodone (REST)Estelle Eyob, Jacob S Shaw, Arnold Bakker, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 19, 2011
Permutation criteria to evaluate multiple clinical endpoints in a proof-of-concept study: lessons from Pre-RELAX-AHFBeth A Davison, Gad Cotter, Hengrui Sun, et al.
JACC. Heart Failure|May 9, 2015
Worsening Heart Failure Following Admission for Acute Heart Failure: A Pooled Analysis of the PROTECT and RELAX-AHF StudiesBeth A Davison, Marco Metra, Gad Cotter, et al.
European Heart Journal|August 29, 2019
A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trialMandeep R Mehra, Muthiah Vaduganathan, Min Fu, et al.
Pageof 19